{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:28:18Z","timestamp":1786980498257,"version":"build-2736575974"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T00:00:00Z","timestamp":1760745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T00:00:00Z","timestamp":1760745600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s10067-025-07757-6","type":"journal-article","created":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T16:35:43Z","timestamp":1760805343000},"page":"5135-5141","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["A case of anti-EJ anti-synthetase syndrome (EJ-ASS) with anti-Ro-52 overlap presenting with progressive interstitial lung disease (ILD) with subtle myopathy \u2014 A case report and literature review"],"prefix":"10.1007","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3241-0229","authenticated-orcid":false,"given":"Ritasman","family":"Baisya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sukdev","family":"Manna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sneha","family":"Dhali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sudip","family":"Ghosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vikas Karamchand","family":"Dagar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,18]]},"reference":[{"issue":"5","key":"7757_CR1","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1097\/CPM.0000000000000171","volume":"23","author":"LJ Witt","year":"2016","unstructured":"Witt LJ, Curran JJ, Strek ME (2016) The diagnosis and treatment of antisynthetase syndrome. Clin Pulm Med 23(5):218\u2013226","journal-title":"Clin Pulm Med"},{"key":"7757_CR2","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1378\/chest.10-0180","volume":"138","author":"GR Connors","year":"2010","unstructured":"Connors GR, Christopher-Stine L, Oddis CV, Danoff SK (2010) Interstitial lung disease associated with the idiopathic inflammatory myopathies: what progress has been made in the past 35 years? Chest 138:1464\u20131474","journal-title":"Chest"},{"key":"7757_CR3","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1590\/S1806-37132011000100015","volume":"37","author":"J Solomon","year":"2011","unstructured":"Solomon J, Swigris JJ, Brown KK (2011) Myositis-related interstitial lung disease and antisynthetase syndrome. J Bras Pneumol 37:100\u2013109","journal-title":"J Bras Pneumol"},{"issue":"2","key":"7757_CR4","first-page":"130","volume":"11","author":"M Cojocaru","year":"2016","unstructured":"Cojocaru M, Cojocaru IM, Chicos B (2016) New insights into antisynthetase syndrome. Maedica (Bucur) 11(2):130\u2013135","journal-title":"Maedica (Bucur)"},{"issue":"9","key":"7757_CR5","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/j.autrev.2014.03.004","volume":"13","author":"JC Lega","year":"2014","unstructured":"Lega JC, Fabien N, Reynaud Q et al (2014) The clinical phenotype associated with myositis-specific and associated autoantibodies: a meta-analysis revisiting the so-called antisynthetase syndrome. Autoimmun Rev 13(9):883\u2013891","journal-title":"Autoimmun Rev"},{"issue":"1","key":"7757_CR6","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1136\/annrheumdis-2012-201800","volume":"73","author":"R Aggarwal","year":"2014","unstructured":"Aggarwal R, Cassidy E, Fertig N (2014) Patients with non-Jo-1 anti-tRNA-synthetase autoantibodies have worse survival than Jo-1 positive patients. Ann Rheum Dis 73(1):227\u2013232","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"7757_CR7","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.4049\/jimmunol.144.5.1737","volume":"144","author":"IN Targoff","year":"1990","unstructured":"Targoff IN (1990) Autoantibodies to aminoacyl-transfer RNA synthetases for isoleucine and glycine. Two additional synthetases are antigenic in myositis. J Immunol 144(5):1737\u20131743","journal-title":"J Immunol"},{"issue":"8","key":"7757_CR8","doi-asserted-by":"publisher","first-page":"2417","DOI":"10.1007\/s10067-020-04979-8","volume":"39","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Ge Y, Yang H (2020) Clinical features and outcomes of the patients with anti-glycyl tRNA synthetase syndrome. Clin Rheumatol 39(8):2417\u20132424","journal-title":"Clin Rheumatol"},{"key":"7757_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2020.105920","volume":"165","author":"Y Liu","year":"2020","unstructured":"Liu Y, Liu X, Xie M (2020) Clinical characteristics of patients with anti-EJ antisynthetase syndrome associated interstitial lung disease and literature review. Respir Med 165:105920","journal-title":"Respir Med"},{"issue":"4","key":"7757_CR10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0060442","volume":"8","author":"Y Hamaguchi","year":"2013","unstructured":"Hamaguchi Y, Fujimoto M, Matsushita T (2013) Common and distinct clinical features in adult patients with anti-aminoacyl-tRNA synthetase antibodies: heterogeneity within the syndrome. PLoS ONE 8(4):e60442","journal-title":"PLoS ONE"},{"issue":"1","key":"7757_CR11","doi-asserted-by":"publisher","DOI":"10.1186\/s12890-016-0325-y","volume":"16","author":"H Sasano","year":"2016","unstructured":"Sasano H, Hagiwara E, Kitamura H et al (2016) Long-term clinical course of anti-glycyl tRNA synthetase (anti-EJ) antibody-related interstitial lung disease pathologically proven by surgical lung biopsy. BMC Pulm Med 16(1):168","journal-title":"BMC Pulm Med"},{"issue":"7","key":"7757_CR12","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.3899\/jrheum.161480","volume":"44","author":"J Shi","year":"2017","unstructured":"Shi J, Li S, Yang H et al (2017) Clinical profiles and prognosis of patients with distinct antisynthetase autoantibodies. J Rheumatol 44(7):1051\u20131057. https:\/\/doi.org\/10.3899\/jrheum.161480","journal-title":"J Rheumatol"},{"key":"7757_CR13","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.872615","volume":"13","author":"N Zhao","year":"2022","unstructured":"Zhao N, Jiang W, Wu H, Wang P, Wang X, Bai Y, Li Y, Tang Y, Liu Y (2022) Clinical features, prognostic factors, and survival of patients with antisynthetase syndrome and interstitial lung disease. Front Immunol 13:872615. https:\/\/doi.org\/10.3389\/fimmu.2022.872615","journal-title":"Front Immunol"},{"issue":"11","key":"7757_CR14","doi-asserted-by":"publisher","DOI":"10.3390\/jcm8112013","volume":"8","author":"L Cavagna","year":"2019","unstructured":"Cavagna L, Trallero-Aragu\u00e1s E, Meloni F et al (2019) Influence of antisynthetase antibodies specificities on antisynthetase syndrome clinical spectrum time course. J Clin Med 8(11):2013","journal-title":"J Clin Med"},{"key":"7757_CR15","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2021-248318","volume":"15","author":"AR Benck","year":"2022","unstructured":"Benck AR, Manadan A (2022) EJ antibody antisynthetase syndrome. BMJ Case Rep 15:e248318","journal-title":"BMJ Case Rep"},{"issue":"Suppl 2","key":"7757_CR16","doi-asserted-by":"publisher","first-page":"ii10","DOI":"10.1093\/rap\/rkab054","volume":"5","author":"SK Sreevilasan","year":"2021","unstructured":"Sreevilasan SK, Devarasetti P, Narahari NK, Desai A, Rajasekhar L (2021) Clinical profile and treatment outcomes in antisynthetase syndrome: a tertiary centre experience. Rheumatol Adv Pract 5(Suppl 2):ii10\u2013ii18","journal-title":"Rheumatol Adv Pract"},{"issue":"7","key":"7757_CR17","doi-asserted-by":"publisher","DOI":"10.1111\/1756-185X.15261","volume":"27","author":"SB Ali","year":"2024","unstructured":"Ali SB, Hender L, Khoo T, Beroukas D, Griggs K, Limaye V (2024) Anti-synthetase syndrome in South Australia over 13 years: a clinical descriptive study. Int J Rheum Dis 27(7):e15261","journal-title":"Int J Rheum Dis"},{"key":"7757_CR18","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1002\/ccr3.3773","volume":"9","author":"R Warner","year":"2021","unstructured":"Warner R, Reid D (2021) Early predominant inflammatory myopathy in anti-glycyl tRNA synthetase (EJ) antibody positive antisynthetase syndrome. Clin Case Rep 9:1376\u20131378","journal-title":"Clin Case Rep"},{"issue":"4","key":"7757_CR19","doi-asserted-by":"publisher","DOI":"10.1111\/bpa.13155","volume":"33","author":"J Tanboon","year":"2023","unstructured":"Tanboon J, Inoue M, Hirakawa S (2023) Muscle pathology of antisynthetase syndrome according to antibody subtypes. Brain Pathol 33(4):e13155","journal-title":"Brain Pathol"},{"key":"7757_CR20","doi-asserted-by":"publisher","first-page":"403","DOI":"10.3109\/14397595.2015.1091155","volume":"26","author":"Y Yamasaki","year":"2016","unstructured":"Yamasaki Y, Satoh M, Mizushima M, Okazaki T, Nagafuchi H, Ooka S et al (2016) Clinical subsets associated with different anti-aminoacyl transfer RNA synthetase antibodies and their association with coexisting anti-Ro52. Mod Rheumatol 26:403\u2013409","journal-title":"Mod Rheumatol"},{"issue":"2006","key":"7757_CR21","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1080\/08916930600623791","volume":"39","author":"R La Corte","year":"2006","unstructured":"La Corte R, Lo Mo Naco A, Locaputo A, Dolzani F, Trotta F (2006) In patients with antisynthetase syndrome the occurrence of anti-Ro\/SSA antibodies causes a more severe interstitial lung disease. Autoimmunity 39(2006):249\u2013253","journal-title":"Autoimmunity"},{"issue":"1","key":"7757_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-024-03382-x","volume":"26","author":"CT Weng","year":"2024","unstructured":"Weng CT, Huang TH, Wu CH, Sun YT (2024) Association of anti-Ro-52 antibodies with occurrence of interstitial lung disease in patients with idiopathic inflammatory myopathy. Arthritis Res Ther 26(1):152","journal-title":"Arthritis Res Ther"},{"key":"7757_CR23","doi-asserted-by":"crossref","unstructured":"Bozzalla-Cassione E, Zanframundo G, Biglia A et al (2022) Anti-Ro52 antibodies positivity in antisynthetase syndrome: a single centre cohort study.\u00a0Clin Exp Rheumatol 134(5):27\u201331","DOI":"10.55563\/clinexprheumatol\/bjb2gf"},{"issue":"1","key":"7757_CR24","doi-asserted-by":"publisher","DOI":"10.1136\/bmjresp-2023-002076","volume":"10","author":"S Nayebirad","year":"2023","unstructured":"Nayebirad S, Mohamadi A, Yousefi-Koma H, Javadi M, Farahmand K et al (2023) Association of anti-Ro52 autoantibody with interstitial lung disease in autoimmune diseases: a systematic review and meta-analysis. BMJ Open Respir Res 10(1):e002076","journal-title":"BMJ Open Respir Res"},{"issue":"8","key":"7757_CR25","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1177\/0961203316651748","volume":"25","author":"R Nakashima","year":"2016","unstructured":"Nakashima R, Hosono Y, Mimori T (2016) Clinical significance and new detection system of autoantibodies in myositis with interstitial lung disease. Lupus 25(8):925\u2013933","journal-title":"Lupus"},{"issue":"5","key":"7757_CR26","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1111\/1346-8138.15274","volume":"47","author":"KM Matsuda","year":"2020","unstructured":"Matsuda KM, Yoshizaki A, Kuzumi A et al (2020) Combined immunosuppressive therapy provides favorable prognosis and increased risk of cytomegalovirus reactivation in anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis. J Dermatol 47(5):483\u2013489","journal-title":"J Dermatol"},{"issue":"11","key":"7757_CR27","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0133702","volume":"10","author":"Y Allenbach","year":"2015","unstructured":"Allenbach Y, Guiguet M, Rigolet A, Marie I, Hachulla E, Drouot L et al (2015) Efficacy of rituximab in refractory inflammatory myopathies associated with anti-synthetase auto-antibodies: an open-label, phase II trial. PLoS ONE 10(11):e0133702","journal-title":"PLoS ONE"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-025-07757-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-025-07757-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-025-07757-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T17:05:45Z","timestamp":1762880745000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-025-07757-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,18]]},"references-count":27,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["7757"],"URL":"https:\/\/doi.org\/10.1007\/s10067-025-07757-6","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,18]]},"assertion":[{"value":"3 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 October 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 October 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent was obtained from the patient for publication of this case report and accompanying images.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}